Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

RBB vs KIDS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

RBB Captures Overall Composite Edge (37.6 SELL vs 45.1 HOLD), While KIDS Leads 3–2 on Growth & Valuation Pillars

RBB Overall Winner 6-Pillar Tally: RBB 2 – 3 KIDS (1 Tie) Matrix Metrics: RBB 6 – 4 KIDS

As of Nov 19, 2026, RBB Bancorp (RBB) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (37.6/100 SELL vs. 45.1/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while KIDS wins 3–2 across the 6-pillar growth and valuation breakdown. RBB trades at $24.41 (10.3x Forward P/E, 43.6% operating margin) versus KIDS at $32.51 (N/M Forward P/E, -8.2% operating margin).

  • Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. RBB 37.6/100 SELL), RBB captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (43.6% vs. -8.2% operating margin) and revenue trajectory (+13.8% vs. +18.6% YoY).
  • Technical & Structure Timing Caution: RBB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.2); meanwhile KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RBB vs KIDS
RBB NASDAQ Head-to-Head Winner
RBB Bancorp Common Stock
State Commercial Banks
$24.41
-1.89% 1D
Market Cap $404.3M
TTM Revenue $131M
Forward P/E 10.3x
Beta / 30D Vol 0.42β · 18% Vol
Unified Composite Score
37.6 / 100 SELL
Tech 11.0 Fund 45.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.2%), weak momentum, RSI 29
RSI-14: 29.2 · SMA20: $25.84 · SMA50: $26.06
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86

6-Pillar Scorecard Institutional Category Breakdown (RBB 2 – 3 KIDS)

Columns: Metric · RBB · KIDS
1. Valuation Multiples RBB
Forward P/E 10.3x N/M
Trailing P/E 9.4x N/M
PEG Ratio N/M N/M
EV / Revenue 3.1x 3.2x
2. Growth & Scale KIDS
Revenue Growth (YoY) +13.8% +18.6%
Earnings Growth (YoY) +25.6% +0.0%
TTM Revenue (USD) $131M $264M
Market Cap $404.3M $850.2M
3. Profitability & Quality RBB
Gross Margin 100.0% 73.8%
Operating Margin 43.6% -8.2%
Net Profit Margin 33.8% -12.8%
Return on Equity (ROE) 8.4% -9.8%
4. Balance Sheet & Cash Flow KIDS
Cash Generation (TTM) N/A $1.1M EBITDA
Cash Flow Margin N/A 0.4% EBITDA Mgn
Net Cash / Leverage $31.75 Book/Sh · 8.4% ROE $12.99 Book/Sh · -9.8% ROE
Dividend Yield 2.57% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 40.7% (7th %ile) 145.1% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 56.4% of Rev ($74M) 82.0% of Rev ($217M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Banks - Regional Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RBB (6) vs KIDS (4)
Institutional Metric RBB KIDS Criterion Row Edge
Market Capitalization
Scale
$404.3M $850.2M Larger Scale KIDS
Trailing P/E Ratio
Valuation
9.4x N/M Lower Multiple RBB
Forward P/E Ratio
Valuation
10.3x N/M Lower Multiple RBB
Revenue Growth (YoY)
Growth
+13.8% +18.6% Higher Growth KIDS
Operating Margin (TTM)
Profitability
43.6% -8.2% Higher Margin RBB
Net Profit Margin
Profitability
33.8% -12.8% Higher Margin RBB
Return on Equity (ROE)
Capital Efficiency
8.4% -9.8% Higher ROE RBB
52-Week Range Position
Momentum
61% ($18–$28) 90% ($14–$35) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
0.42β · 18% Vol 0.81β · 108% Vol Lower Realized Risk RBB
Unified Institutional Score
Composite Signal
37.6 / 100 (SELL) 45.1 / 100 (HOLD) Higher Composite KIDS
Trailing 12M Revenue (USD)
Operating Scale
$131M $264M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 73.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.1x EV/Rev N/M PEG · 3.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($31.75 Book/Sh · 8.4% ROE) $1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +43.75 pp
RBB: -7.38% · KIDS: +36.37%
3M Horizon KIDS +35.11 pp
RBB: -8.37% · KIDS: +26.74%
6M Horizon KIDS +73.66 pp
RBB: +2.74% · KIDS: +76.4%
1Y Horizon KIDS +67.67 pp
RBB: +31.17% · KIDS: +98.84%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBB vs KIDS. Trailing 12-month operating profitability (RBB 43.6% vs KIDS -8.2%) and valuation multiples (RBB 10.3x vs KIDS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

RBB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$131M
Gross Margin100.0%
Op. Margin43.6%
ROE / Fwd P/E8.4% · 10.3x
KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RBB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 40.7%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RBB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RBB Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $404.3M market capitalization and 43.6% operating margin.
OpEx & R&D Reinvestment 56.4% of Rev ($74M)
90D Engineering Disclosures 0 Published
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published

Investor FAQ RBB vs KIDS Key Questions & Quantitative Answers

As of Nov 19, 2026, RBB Bancorp (RBB) captures the overall head-to-head institutional edge over OrthoPediatrics Corp. (KIDS) on higher Unified Composite conviction (37.6/100 SELL vs. 45.1/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while KIDS wins 3–2 across the 6-pillar growth and valuation breakdown. RBB trades at $24.41 (10.3x Forward P/E, 43.6% operating margin) versus KIDS at $32.51 (N/M Forward P/E, -8.2% operating margin). Composite vs. Pillar Nuance: While KIDS currently prints a higher short-term Unified Composite Score (45.1/100 HOLD vs. RBB 37.6/100 SELL), RBB captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (43.6% vs. -8.2% operating margin) and revenue trajectory (+13.8% vs. +18.6% YoY). Technical & Structure Timing Caution: RBB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.2); meanwhile KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KIDS leads the Growth & Scale pillar: RBB posts +13.8% YoY revenue growth and +25.6% YoY earnings growth on $131M TTM revenue (100.0% gross margin, 43.6% operating margin), compared with KIDS at +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin). On trailing 12-month operating scale, RBB generates $131M in USD-normalized revenue versus $264M for KIDS. In operating R&D and SG&A reinvestment, RBB deploys 56.4% of Rev ($74M) (0 90-day corporate R&D disclosures) versus 82.0% of Rev ($217M) (0 disclosures) for KIDS.

RBB screens cheaper on headline valuation multiples. RBB trades at 10.3x Forward P/E, 9.4x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (unreported cash flow margin), whereas KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RBB (8.4% ROE) versus KIDS (-9.8% ROE) capital efficiency.

In options market volatility and institutional positioning, RBB carries 40.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.42β · 18% Vol realized risk). By comparison, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.